<a id='f931caf6-1974-44f7-ba34-a617876307b4'></a>

<::A collection of medical devices, likely for intravenous access or catheterization, is displayed on a light background with a blue border. The items include:
- A blue and clear syringe.
- Several needles and introducers of various sizes.
- A long, thin, light blue catheter or guide wire.
- A clear, coiled tube, possibly a catheter or extension line, with multiple blue and yellow connectors and ports.
- Various small white and blue plastic components such as caps, hubs, and clamps.
- A blue Y-connector.
: figure::>

<a id='2ae3bd94-bf13-4373-b2a7-6d77b1cf471c'></a>

<::An image showing a white plastic tray containing three clear plastic IV bags, likely for pediatric use. The bags are filled with a clear liquid and have labels with text. 

**Left Bag (partially visible):**
- "Baxter"
- "Pediatric"
- "Dextrose"
- "Sodium Chloride"
- "Potassium Chloride"
- "Calcium Gluconate"
- "Magnesium Sulfate"
- "Phosphate"
- "Zinc"
- "Copper"
- "Manganese"
- "Chromium"
- "Selenium"
- "Iodine"
- "Molybdenum"
- "Fluoride"
- "Iron"
- "Vitamin K"
- "Folic Acid"
- "Biotin"
- "Pantothenic Acid"
- "Niacin"
- "Riboflavin"
- "Thiamine"
- "Pyridoxine"
- "Cyanocobalamin"
- "Ascorbic Acid"
- "Vitamin A"
- "Vitamin D"
- "Vitamin E"

**Middle Bag:**
- "Pediatric ace 500 ml"
- Contains detailed instructions and ingredient information, largely unreadable but includes phrases like "Pediatric ace 500 ml" repeated.
- "2PL058470"

**Right Bag (partially visible):**
- "Pediatric"
- Contains ingredient information, similar to the left bag.
- "2006"

All bags have ports at the bottom. The entire assembly is presented on a blue background.
: figure::>

<a id='5816cde4-8e27-48d5-9bbf-055d4e9036d6'></a>

Overview of
Parenteral Nutrition
for the
Pediatric Patient

<a id='344cd3a0-7962-4b84-b391-7c2fa6441572'></a>

<::NASPGHAN FOUNDATION logo with "NASPGHAN" in dark blue, bold, italicized text and "FOUNDATION" in red, bold text below it, all on a blue gradient background.::>

<a id='bf347e07-90a1-4845-8ff7-c5dc639c07d2'></a>

SUPPORTED BY AN EDUCATIONAL GRANT FROM FRESENIUS KABI

FRESENIUS
KABI

<a id='3561de18-5cb5-4e47-a111-1d16e5364556'></a>

CAPTION ERROR

<a id='df2ae853-33cc-4ee6-8727-64ad98337b01'></a>

<table><thead><tr><th>COURSE DIRECTOR</th><th>CO-CHAIR</th></tr></thead><tbody><tr><td>Debora Duro, MD, MS<br>Salah Foundation Children Hospital at<br>Broward Health, Fort Lauderdale, Florida<br>NOVA Southeastern University and<br>Florida International University</td><td>Kathleen Gura, PharmD, BCNSP<br>Boston Children's Hospital<br>Harvard Medical School</td></tr></tbody></table>

<a id='a75b89a4-2953-4451-9cec-52e46c810962'></a>

<::NASPGHAN FOUNDATION logo::>

<a id='856b77d5-eb61-4bf5-9f55-0cc84d95d943'></a>

CAPTION ERROR

<a id='7c2d7e9b-7a16-4eaf-883f-b66d4164e60d'></a>

# FACULTY

**Atu Agawu, MD**
Children's Hospital Los Angeles
University of Southern California

**Bridget Kiernan, MD**
NYU Hassenfeld Children's Hospital
New York University Langone Health

**Valerie Marchand, MD**
Ste-Justine University Hospital Center
University of Montreal

**Danielle Wendel, MD**
Seattle Children's Hospital
University of Washington

**Justine Turner, MBBS, FRACP, PhD**
University of Alberta

<a id='a9bd9841-dae4-4379-b3d4-6fef048d2598'></a>

Alvin Chan, MD, MPH
Mattel Children's Hospital
University of California

Joanne Lai, MD
Icahn School of Medicine
Mount Sinai Hospital, New York

Nikhil Pai, MD
Children's Hospital of Philadelphia
University of Pennsylvania

Timothy Sentongo, MD
Comer Children's Hospital
University of Chicago

Rebecca Pipkorn, RD, CD, CNSC
Children's Wisconsin

<a id='8526ab90-72d4-4c8a-b8b4-265b002ceb29'></a>

<::NASPGHAN FOUNDATION
: figure::>

<a id='036d2362-6a57-4743-8296-70cf3b4795d7'></a>

CAPTION ERROR

<a id='8dec9765-8bfb-4dee-8e88-d1129c762997'></a>

# Faculty Disclosure

**Atu Agawu**
None

**Alvin Chan**
None

**Debora Duro**
Speaker's Bureau: Alcresta, Kate Farms, Abbott Nutrition, Fresenius Kabi

**Kathleen Gura**
Advisory Board: NorthSea Therapeutics, B Braun, Baxter
Consultant: Fresenius Kabi, NorthSea Therapeutics, Alcresta, Lexicomp®, Takeda, Mead Johnson/Reckitt, Otsuko Pharmaceuticals
Patents/Royalties: for use of Omegaven®
Royalties: UpToDate®, Lexicomp®

<a id='7baf1244-49de-40bf-bc92-0778de9548ac'></a>

<::NASPGHAN FOUNDATION
: figure::>

<a id='7df0f92c-b8e1-4829-a040-e33baa3d7977'></a>

CAPTION ERROR

<a id='69a837cf-ee7c-4ac0-8955-c12b81c6e981'></a>

## Faculty Disclosure – Cont'd

<table><thead><tr><th>Name</th><th>Disclosure</th></tr></thead><tbody><tr><td>Bridget Kiernan</td><td>None</td></tr><tr><td>Joanne Lai</td><td>None</td></tr><tr><td>Valerie Marchand</td><td>Speaker's Bureau: Nestlé, Modilac®, Abbott</td></tr><tr><td>Nikhil Pai</td><td>Speaker's Bureau: Takeda, Abbott</td></tr><tr><td>Rebecca Pipkorn</td><td>None</td></tr><tr><td>Timothy Sentongo</td><td>None</td></tr><tr><td>Justine Turner</td><td>Research Funding: Baxter Healthcare</td></tr><tr><td>Danielle Wendel</td><td>None</td></tr></tbody></table>

<a id='d71acd5e-7a25-4c2b-9b80-add5035d8bd6'></a>

NASPGHAN
FOUNDATION

<a id='c6159c12-5388-4671-9907-0bc10f834cae'></a>

CAPTION ERROR

<a id='66988c34-6f69-4fe3-bd8f-c9cfa1e4981b'></a>

<table id="5-1">
<tr><td id="5-2" colspan="3">Abbreviations</td></tr>
<tr><td id="5-3">AKI: acute kidney injury ALA: α-linolenic acid ARA: arachidonic acid</td><td id="5-4">BMI: body mass index BCAA: branch chain amino acid</td><td id="5-5">CIF: chronic intestinal failure CLD: chronic liver disease CRRT: continuous RRT CLABSI: central line associated bloodstream infection CVC: central line catheter</td></tr>
<tr><td id="5-6">DHA: docosahexaenoic acid DRI: dietary reference intake</td><td id="5-7">EAR: estimated average requirement EFA: essential fatty acids EFAD: essential fatty acid deficiency EPA: eicosapentaenoic acid ESRD: end-stage renal</td><td id="5-8">FO-ILE: fish oil-based ILE (Omegaven®)</td></tr>
<tr><td id="5-9">GIR: glucose infusion rate GH: growth hormone</td><td id="5-a">HD: hemodialysis HTG: hypertriglyceridemia</td><td id="5-b">IFALD: intestinal Failure associated liver disease IGF: insulin-like growth factor ILE: intravenous lipid emulsion I/Os: ins and outs INR: international normalized ratio</td></tr>
</table>

<a id='e50b5ce6-17e2-46d0-a0d4-52c8ed0f593c'></a>

<::transcription of the content: NASPGHAN FOUNDATION logo with stylized text on a blue gradient background::>

<a id='82a43daf-2ea6-48b4-9dd6-3471c7177873'></a>

<::logo: NASPGHAN
NASPGHAN
The logo features the dark blue, bold, italicized text "NASPGHAN" on a light blue gradient background, with a dark blue curved line sweeping beneath the text.::>

<a id='3127916f-5648-4b7f-9bb7-f22076e14726'></a>

# Abbreviations – Cont'd
<table id="6-1">
<tr><td id="6-2">LA: linoleic acid LCT: long-chain triglycerides LFT: liver function test</td><td id="6-3">MBD: metabolic bone disease MCT: medium-chain triglycerides MET: metabolic equivalents MMA: methylmalonic acidemia MSUD: maple syrup urine disease MVI: multivitamin</td><td id="6-4">OO: olive oil-based ILE OO, SO-ILE: olive soy, oil-based ILE (Clinolipid®)</td></tr>
<tr><td id="6-5" rowspan="2">PD: peritoneal dialysis PICC: peripherally inserted central catheter PIVKA-II: protein induced in vit. K absence PIRRT: prolonged intermittent RRT PN: parenteral nutrition PT: prothrombin time</td><td id="6-6" rowspan="2">RDA: recommended daily allowance RDR: retinal dose response RRT: renal replacement therapy</td><td id="6-7" rowspan="2">SUN: serum urea nitrogen SMOF: SO, MCT, OO, FO-ILE SO-ILE: soy oil-based ILE</td></tr>
<tr><td id="6-8">T:T: triene:tetraene ratio</td><td id="6-9">UCD: urea cycle disorders</td><td id="6-a"></td></tr>
</table>

<a id='a469f608-e5c0-4069-b3c5-fd1e8156e2d3'></a>

NASPGHAN
FOUNDATION

<a id='d2b18b12-dac3-4e32-8a1d-14cb12530af4'></a>

CAPTION ERROR

<a id='492b42ba-b6d6-42a7-b86f-84b445e94bf2'></a>

# Overview

*   History of pediatric parenteral nutrition (PN)
*   Clinical indications for PN in the pediatric patient
*   Administration routes for PN
*   Components of pediatric PN
    *   Macronutrients
    *   Micronutrients
    *   Trace elements

<a id='87e89c0c-f9d1-4980-a668-c0e20680cc6d'></a>

<::NASPGHAN FOUNDATION logo::>

<a id='ad6a6dc7-6464-4dd1-82b3-5c116f5d1326'></a>

CAPTION ERROR

<a id='589b325c-b64d-4de1-9b3f-bcaedd770e94'></a>

# Case

*   Jerry is a previously healthy 13-year-old male. He was transferred from an outside hospital after undergoing exploratory laparotomy for a complicated perforated appendicitis. Due to extensive lysis of adhesions and inflamed bowel, the decision was made to create an ileostomy 100 cm distal to the ligament of Treitz.
*   Since surgery he has been having 75 - 100 mL/kg of ostomy output daily. He will be NPO for at least 1 week while receiving IV antibiotics for his intra-abdominal infection secondary to intestinal perforation.
Question: What is the most appropriate way to provide adequate

<a id='9b5ab4a2-f0dc-4203-a8e5-8ff27a16e1c0'></a>

hydration and nutrition to GE?

<a id='3e05ed72-ce94-4ffb-ac40-a8427c4e69bb'></a>

<::NASPGHAN FOUNDATION logo: figure::>

<a id='590b33ed-0cd1-46e4-b28d-145f65129f61'></a>

CAPTION ERROR